Patents Assigned to Calando Pharmaceuticals
  • Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
    Publication number: 20060263435
    Abstract: The present application relates to inhibitors of ribonucleotide reductase subunit 2 (R2), and methods and compositions related to the R2 inhibitors. In certain embodiments, the R2 inhibitors include nucleic acids, such as for example siRNAs.
    Type: Application
    Filed: March 31, 2006
    Publication date: November 23, 2006
    Applicant: Calando Pharmaceuticals
    Inventors: Mark Davis, Jeremy Heidel, John Rossi